BS-1417

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBS-1417
Drug Alias Nameintegrin antagonist (Dainippon)integrin alpha-V/beta-3 antagonist (Dainippon)BS-1417
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDainippon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDainippon Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A